Stay updated on Primary Oral Insulin Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.

Latest updates to the Primary Oral Insulin Immunotherapy Clinical Trial page
- CheckyesterdayChange DetectedLocations section now lists multiple sites across Belgium, Germany (Bavaria, Lower Saxony, Saxony), Poland, Sweden, and the UK, and a new POInT publication citation was added.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA minor site revision was implemented (v3.3.2) replacing the previous revision (v3.3.1); there are no changes to study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA new publication entry, 'Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial', was added to Publications. The Publications description was updated from 'These publications come from PubMed...' to 'These publications are automatically filled in from PubMed...'.SummaryDifference0.2%

- Check37 days agoChange DetectedRemoval of the temporary government-funding notice previously displayed on the page; this affects only operating-status messaging and does not alter study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe Study Details page content appears unchanged between versions; the main sections (brief summary, inclusion criteria, design, outcomes, and locations) remain the same.SummaryDifference0.4%

- Check80 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to Primary Oral Insulin Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.